Florian Holsboer

Florian Holsboer was born in Munich, went to school there, graduated from high school and completed his studies in chemistry and medicine with dissertations (theoretical chemistry and genetics). After further training as a specialist in psychiatry at the University of Mainz, he habilitated in 1984, was appointed to the Chair of Psychiatry in Freiburg in 1987 and to the Director of the Max Planck Institute of Psychiatry in Munich in 1989. Florian Holsboer is author or co-author of over 1000 scientific publications and is one of the most cited scientists worldwide.

In July 2014, he decided to leave the Max Planck Institute and take over as CEO of the pharmaceutical company HMNC Brain Health.

Professor Holsboer is one of the most internationally renowned depression researchers. He is known for his discoveries about the connection between stress, depression, anxiety and sleep disorders, the laboratory diagnostic characterization of these diseases and their best treatment. He is considered one of the founders of personalized depression therapy, which, based on laboratory diagnostics, helps optimize the treatment of depression.

Florian Holsboer has received numerous awards, including the Gay Lussac Humboldt Prize (France), the Luis Federico Leloir Prize (Argentina), the Freedom to Discover Award (USA), the Wagner v. Jauregg Medal (Austria), the Anna Monika Price, the Robert Pfleger Research Prize, and the Zülch Prize (all Germany). He holds honorary doctorates from the Universities of Leiden (Holland) and Zurich (Switzerland).

As of January 2021, he is a member of the Supervisory Board of HMNC Holding GmbH and heads the Scientific Advisory Board.